Inaugural Article: Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Role and therapeutic potential of the NEDD4 family in breast cancer

  2025cites this paper
• Sex-dimorphic tumor growth is regulated by tumor microenvironmental and systemic signals

  2024cites this paper
• A biochemical assessment of apoptosis-inducing impact of Salinomycin in combination with ciprofloxacin on human leukemia KG1–a stem-like cells in the presence and absence of insulin

  2024cites this paper
• Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer

  2023cites this paper
• Quantitative ratio of mRNA expression of IGF/INS system receptors in multiple myeloma

  2023cites this paper
• Multifaceted involvements of Paneth cells in various diseases within intestine and systemically

  2023cites this paper
• Anticancer activity of apple peel extracts against human breast cancer cells through insulin-like growth factor-1 signal transduction pathway

  2023cites this paper
• Molecular imaging of pancreatic ductal adenocarcinoma

  2023cites this paper
• Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance

  2023cites this paper
• IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?

  2023cites this paper
• NTRK1-mediated protection against manganese-induced neurotoxicity and cell apoptosis via IGF2 in SH-SY5Y cells.

  2023cites this paper
• Autocrine IGF-II-Associated Cancers: From a Rare Paraneoplastic Event to a Hallmark in Malignancy

  2023cites this paper
• Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors

  2023cites this paper
• Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms

  2022cites this paper
• N-Linked Glycosylation in Chinese Hamster Ovary Cells Is Critical for Insulin-like Growth Factor 1 Signaling

  2022cites this paper
• Computational Drug Repurposing Based on a Recommendation System and Drug–Drug Functional Pathway Similarity

  2022cites this paper
• Cixutumumab reveals a critical role for IGF-1 in adipose and hepatic tissue remodelling during the development of diet-induced obesity

  2022cites this paper
• Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor

  2022cites this paper
• Subventricular zone adult mouse neural stem cells require insulin receptor for self-renewal

  2022cites this paper
• Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival

  2022cites this paper
• Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrier

  2022cites this paper
• The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular

  2022cites this paper
• Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation

  2022cites this paper
• Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

  2021cites this paper
• RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo

  2021cites this paper
• Cellular property and potential functions of insulin receptor (IR) induced by IGF-1/insulin on lung cancer cells

  2021cites this paper
• A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer.

  2021cites this paper
• MiR-221 Expression Level Correlates with Insulin-Induced Doxorubicin Resistance in MCF-7 Breast Cancer Cells

  2021cites this paper
• Diabetes Mellitus as a Prognostic Factor for Locally Advanced Rectal Cancer

  2021cites this paper
• The emerging role of the fetal insulin receptor (IR-A) in hormone-refractory breast cancer.

  2021cites this paper
• Hyperinsulinemia in Obesity, Inflammation, and Cancer

  2021cites this paper
• Insulin and the insulin receptor collaborate to promote human gastric cancer

  2021cites this paper
• Subventricular zone adult mouse neural stem cells and human glioblastoma stem cells require insulin receptor for self-renewal

  2020cites this paper
• Insulin resistance contributes to racial disparities in breast cancer prognosis in US women

  2020cites this paper
• The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer

  2020cites this paper
• IGF2 drives formation of ileal neuroendocrine tumors in patients and mice.

  2020cites this paper
• Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy

  2020cites this paper
• The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives

  2020cites this paper
• Imatinib Revives the Therapeutic Potential of Metformin on Ewing Sarcoma by Attenuating Tumor Hypoxic Response and Inhibiting Convergent Signaling Pathways.

  2020cites this paper
• Hyperinsulinaemia in cancer

  2020cites this paper
• Lifestyle Factors in Cancer

  2020cites this paper
• Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma

  2020cites this paper
• Regulation of Telomerase Activity by Rab5 Guanine Nucleotide Exchange Factors

  2020cites this paper
• Isoform- and Paralog-Switching in IR-Signaling: When Diabetes Opens the Gates to Cancer

  2020cites this paper
• Advances in insulin-like growth factor biology and -directed cancer therapeutics.

  2020cites this paper
• Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer

  2020cites this paper
• Targeting protein kinases for anti-glioma treatment.

  2020influential citation
• Downregulation of the let-7 family of microRNAs may promote insulin receptor/insulin-like growth factor signalling pathways in pancreatic ductal adenocarcinoma

  2020cites this paper
• Hyperinsulinaemia in cancer

  2020cites this paper
• Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor–binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinoma

  2019cites this paper
• Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes

  2019cites this paper
• The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update

  2019cites this paper
• Therapeutic Targeting of the IGF Axis

  2019cites this paper
• Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.

  2019cites this paper
• Computational Analysis of Insulin-Glucagon Signalling Network: Implications of Bistability to Metabolic Homeostasis and Disease states

  2019cites this paper
• Insulin promotes invasion and migration of KRASG12D mutant HPNE cells by upregulating MMP‐2 gelatinolytic activity via ERK‐ and PI3K‐dependent signalling

  2019cites this paper
• Alleles of Insm1 determine whether RIP1-Tag2 mice produce insulinomas or nonfunctioning pancreatic neuroendocrine tumors

  2019cites this paper
• Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features.

  2019cites this paper
• Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia

  2018influential citation
• Insulin Receptor Isoforms in Cancer

  2018cites this paper
• Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer

  2018cites this paper
• Receptor Tyrosine Kinase-Targeted Cancer Therapy

  2018cites this paper
• Antitumor effects of β-elemene via targeting the phosphorylation of insulin receptor

  2018cites this paper
• MiR-99b-5p and miR-203a-3p Function as Tumor Suppressors by Targeting IGF-1R in Gastric Cancer

  2018cites this paper
• Impact of insulin on primary arcuate neurons culture is dependent on early-postnatal nutritional status and neuronal subpopulation

  2018cites this paper
• Analysis of potential driver genes in oral squamous cell carcinoma

  2018cites this paper
• Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer.

  2017cites this paper
• Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors.

  2017cites this paper
• Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms

  2017cites this paper
• IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1

  2017cites this paper
• Insights into the Link Between Obesity and Cancer

  2017cites this paper
• Scientific rationale for integrative and personalised strategies for pancreatic ductal adenocarcinoma management

  2017influential citation
• IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights

  2017cites this paper
• Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells.

  2017cites this paper
• Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF‐1/IGF‐1R signaling

  2017cites this paper
• Emerging antibodies for the treatment of pancreatic cancer

  2017cites this paper
• Insulin‐like growth factor axis targeting in cancer and tumour angiogenesis – the missing link

  2017cites this paper
• Microenvironmental Regulation of Tumor Resistance to Anti-IGF-1R Monoclonal Antibody

  2017influential citation
• Insulin Receptor Isoforms in Physiology and Disease: An Updated View

  2017cites this paper
• Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI‐906) or Placebo in Chemotherapy‐Naive Patients With Non–Small‐Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations

  2017cites this paper
• Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer

  2017cites this paper
• MicroRNA-592 targets IGF-1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma

  2017cites this paper
• Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress

  2017cites this paper
• Randomized phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non–small cell lung cancer

  2016influential citation
• BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549

  2016cites this paper
• Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.

  2016cites this paper
• Interacciones entre las células madre pluripotentes del carcinoma embrionario y las células mioides peritubulares del testículo

  2016cites this paper
• Involvement of Igf1r in Bronchiolar Epithelial Regeneration: Role during Repair Kinetics after Selective Club Cell Ablation

  2016cites this paper
• Practical Guidelines for Incorporating Knowledge-Based and Data-Driven Strategies into the Inference of Gene Regulatory Networks

  2016cites this paper
• Association of Bactericidal Dysfunction of Paneth Cells in Streptozocin-Induced Diabetic Mice with Insulin Deficiency

  2016cites this paper
• IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin

  2016cites this paper
• Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling

  2016cites this paper
• Type I insulin-like growth factor receptor signaling in hematological malignancies

  2016cites this paper
• Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors

  2016cites this paper
• Differential Regulation of IGF-1 and Insulin Signaling by GRKs

  2016cites this paper
• CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy

  2016cites this paper
• Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer

  2016cites this paper
• Sexual dimorphism of liver metastasis by murine pancreatic neuroendocrine tumors is affected by expression of complement C5

  2016cites this paper
• Mouse Models Used to Study the Effects of Diabetes, Insulin, and IGFs on Cancer

  2015cites this paper
• The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins

  2015cites this paper